Bottom Line: Cerebral spinal fluid (CSF) levels of (and) #946;-amyloid 42(A (and) #946;42) are linked with the diagnosis of Alzheimer disease (AD) and (A (and) #946;) accumulation in the brain independent of apolipoprotein E (APOE) gene makeup. Authors: Ronald Lautner, M.D., of Sahlgrenska University Hospital, Sweden, and colleagues. Background: With the emergence of biomarker dementia diagnostics, interest in CSF biomarkers associated with AD, including A (and) #946;42 and ...
Read More
You have just read an article categorized health
titled Diagnostic Accuracy of Cerebral Spinal Fluid Biomarkers for Alzheimer Disease.
Written by:
editor -
Monday, September 1, 2014
There are currently no comments for "Diagnostic Accuracy of Cerebral Spinal Fluid Biomarkers for Alzheimer Disease"
Post a Comment